CSIMarket
 
Molecular Templates Inc   (NASDAQ: MTEM)
 

Molecular Templates Inc's Customers Performance

MTEM



 
MTEM's Source of Revenues During the corresponding time, Molecular Templates Inc sequentially revenue fell by -94.84 %. While revenue at the Molecular Templates Inc 's corporate clients

List of MTEM Customers




for the same period Molecular Templates Inc sequentially revenue fell by -94.84 %.

List of MTEM Customers

Molecular Templates Inc's Business Units






Molecular Templates Inc's Comment on Sales, Marketing and Customers



The FDA's regulatory framework for biological products includes Orphan Drug Designation and Exclusivity for treatments targeting rare diseases affecting fewer than 200,000 individuals in the United States or conditions with no reasonable expectation of cost recovery. In December 2019, the FDA granted Orphan Drug Designation to MT-0169 for the treatment of multiple myeloma. Additionally, the FDA offers expedited development and review programs for products addressing unmet medical needs in serious or life-threatening diseases, such as fast track designation, breakthrough therapy designation, priority review designation, and an oncology-specific real-time review program.





Molecular Templates Inc’s Comment on Sales, Marketing and Customers


The FDA's regulatory framework for biological products includes Orphan Drug Designation and Exclusivity for treatments targeting rare diseases affecting fewer than 200,000 individuals in the United States or conditions with no reasonable expectation of cost recovery. In December 2019, the FDA granted Orphan Drug Designation to MT-0169 for the treatment of multiple myeloma. Additionally, the FDA offers expedited development and review programs for products addressing unmet medical needs in serious or life-threatening diseases, such as fast track designation, breakthrough therapy designation, priority review designation, and an oncology-specific real-time review program.








MTEM's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Molecular Templates Inc 0.00 60.31 -48.46 62
SUBTOTAL 0.00 0.00 0.00 -

Sources: Molecular Templates Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Molecular Templates Inc’s corporate clients.
For your research, we’ve provided 9 tables on Molecular Templates Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.